M2TEST
BES TEST: nuovo esame diagnostico, brevettato e validato, per la valutazione dell’elasticità dell’osso
BES TEST: nuovo esame diagnostico, brevettato e validato, per la valutazione dell’elasticità dell’osso
M2TEST is an innovative startup operating as a SAAS provider, offering the BES TEST: a patented and validated diagnostic test for assessing bone elasticity. The company's goal is to improve people's lives through the prevention and monitoring of fracture risk with a validated, simple, and safe test. The BES TEST evaluates bone quality, not only in cases of osteoporosis and/or osteopenia, but also in short-term monitoring of bone alterations caused by specific drug treatments. Founded in 2016 and based in Italy, M2TEST operates in the Health Care and Medical Devices industries. As of now, there is no available information on the latest investment or the investors involved.
There is no investment information
No recent news or press coverage available for M2TEST.
We care about your data, and we'd love to use cookies make your experience better.
